Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Pierce

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Cell Death & Disease|October 21, 2020
EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewalRoberto Paredes, James R Kelly, Bethany Geary, et al.
Nucleic Acids Research|August 14, 2018
Erratum: EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Nucleic Acids Research|June 26, 2018
EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Cell Death & Disease|June 16, 2017
Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruptionStefan Meyer, Adam Stevens, Roberto Paredes, et al.
Science Advances|June 26, 2018
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor modelsStephen T Durant, Li Zheng, Yingchun Wang, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Cell Death & Disease|October 21, 2020
EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewalRoberto Paredes, James R Kelly, Bethany Geary, et al.
Nucleic Acids Research|August 14, 2018
Erratum: EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Nucleic Acids Research|June 26, 2018
EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Cell Death & Disease|June 16, 2017
Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruptionStefan Meyer, Adam Stevens, Roberto Paredes, et al.
Science Advances|June 26, 2018
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor modelsStephen T Durant, Li Zheng, Yingchun Wang, et al.
Pageof 8